The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
Home Explore Non-Alcoholic Steatohepatitis (NASH) treatment market eyes $94B milestone by next decade
View in Fullscreen

The Non-Alcoholic Steatohepatitis (NASH) treatment market is set to grow rapidly. It is expected to rise from US$ 7.9 billion in 2024 to about US$ 94.0 billion by 2034, growing at a CAGR of 28.1% during the forecast period.

Like this book? You can publish your book online for free in a few minutes!
Share

Related Publications

Discover the best professional documents and content resources in AnyFlip Document Base.
Search
Published by harrietteracine23, 2025-07-02 00:35:09

Non-Alcoholic Steatohepatitis (NASH) treatment market eyes $94B milestone by next decade

The Non-Alcoholic Steatohepatitis (NASH) treatment market is set to grow rapidly. It is expected to rise from US$ 7.9 billion in 2024 to about US$ 94.0 billion by 2034, growing at a CAGR of 28.1% during the forecast period.

Keywords: Non-Alcoholic Steatohepatitis (NASH) treatment market size, Non-Alcoholic Steatohepatitis (NASH) treatment market Share, Non-Alcoholic Steatohepatitis (NASH) treatment market Growth

Click to View FlipBook Version